Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126784001 | 12678400 | 1 | I | 20160726 | 20160823 | 20160823 | PER | US-ASTRAZENECA-2016SE80740 | ASTRAZENECA | 0.00 | F | Y | 70.30000 | KG | 20160823 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126784001 | 12678400 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | U | 20541 | 1 | MG | TABLET | QD | ||||||
126784001 | 12678400 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | .5 | MG | TABLET | QOD | |||||||
126784001 | 12678400 | 3 | SS | LETROZOLE. | LETROZOLE | 1 | Oral | U | 0 | 2.5 | MG | TABLET | QD | ||||||
126784001 | 12678400 | 4 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
126784001 | 12678400 | 5 | C | VITAMINS | VITAMINS | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126784001 | 12678400 | 1 | Breast cancer female |
126784001 | 12678400 | 2 | Blood cholesterol abnormal |
126784001 | 12678400 | 3 | Breast cancer female |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126784001 | 12678400 | Alopecia | |
126784001 | 12678400 | Arthralgia | |
126784001 | 12678400 | Insomnia | |
126784001 | 12678400 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |